• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

BRD4 Inhibitor-20

CAS No. 2490311-14-1

BRD4 Inhibitor-20 ( —— )

产品货号. M35542 CAS No. 2490311-14-1

BRD4 Inhibitor-20 是一种有效的溴结构域蛋白 4 (BRD4) 抑制剂,具有口服活性。 BRD4 Inhibitor-20 对 BRD4 (BD1) 和BRD4 (BD2) 具有抑制活性,IC50 值分别为 19 nM 和 28 nM。 BRD4 Inhibitor-20 在癌细胞系中也具有抗增殖活性。 BRD4 Inhibitor-20 可用于结肠癌等多种癌症的研究。

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥530 有现货
10MG ¥872 有现货
25MG ¥1423 有现货
50MG ¥2046 有现货
100MG ¥2682 有现货
200MG ¥3573 有现货
500MG 获取报价 有现货
1G 获取报价 有现货
1 mL x 10 mM in DMSO ¥560 有现货

生物学信息

  • 产品名称
    BRD4 Inhibitor-20
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    BRD4 Inhibitor-20 是一种有效的溴结构域蛋白 4 (BRD4) 抑制剂,具有口服活性。 BRD4 Inhibitor-20 对 BRD4 (BD1) 和BRD4 (BD2) 具有抑制活性,IC50 值分别为 19 nM 和 28 nM。 BRD4 Inhibitor-20 在癌细胞系中也具有抗增殖活性。 BRD4 Inhibitor-20 可用于结肠癌等多种癌症的研究。
  • 产品描述
    BRD4 Inhibitor-20 is a potent orally active bromodomain protein 4 (BRD4) inhibitor. BRD4 Inhibitor-20 has inhibitory activity for BRD4 (BD1) and BRD4 (BD2) with IC50 values of 19 nM and 28 nM, respectively. BRD4 Inhibitor-20 also has anti-proliferation activities in cancer cell lines. BRD4 Inhibitor-20 can be used for the research of kinds of cancer, such as colon cancer.
  • 体外实验
    BRD4 Inhibitor-20 (compound 12j) exhibits excellent BRD4 inhibitory activities (BD1, IC50=19 nM; BD2, IC50=28 nM) and inhibitory activities against BRD2 (BD1, IC50=24 nM; BD2, IC50=18 nM).BRD4 Inhibitor-20 (0.5, 2.5, 5.0 μM; 24 h) reduces the expression of c-Myc.BRD4 Inhibitor-20 (72 h) has anti-proliferation potency with IC50 values of 4.75 μM, 1.35 μM and 44.07 μM in HT-29, HL-60 and WI-38 cells, respectively.BRD4 Inhibitor-20 (2.5, 5.0, 10.0 μM; 24 h) can arrest the cell-cycle progression of HT-29 cells into the G1 phaseWestern Blot Analysis Cell Line:HT-29 cells Concentration:0.5, 2.5, 5.0 μM Incubation Time:24 h Result: Displayed profound inhibitory effects on c-Myc protein expression.Cell Proliferation Assay Cell Line:HT-29, HL-60 and WI-38 cells Concentration:Incubation Time:72 h Result:Possessed strong anti-proliferative activity and weak toxicity.Cell Cycle Analysis Cell Line:HT-29 cell lines Concentration:2.5, 5.0, 10.0 μM Incubation Time:24 h Result:Arrested the cell-cycle progression of the cell line into the G1 phases and the percentage of cells in G1 phase after treatment under concentrations of 2.5, 5.0 and 10.0 μM were 85.98%, 86.49% and 86.05%, respectively.
  • 体内实验
    BRD4 Inhibitor-20 (compound 12j) (i.v., 5 mg/kg; p.o, 15mg/kg) exhibits favorable oral pharmacokinetic propertie.
  • 同义词
    ——
  • 通路
    Chromatin/Epigenetic
  • 靶点
    Epigenetic Reader Domain
  • 受体
    Epigenetic Reader Domain
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    2490311-14-1
  • 分子量
    358.41
  • 分子式
    C18H18N2O4S
  • 纯度
    >98% (HPLC)
  • 溶解度
    In Vitro:?DMSO 中的溶解度 : 125 mg/mL (348.76 mM; 超声助溶 (<60°C)
  • SMILES
    C(C)(C)=C1C=2C(NC1=O)=CC=C(NS(=O)(=O)C3=C(OC)C=CC=C3)C2
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

1. Yu Xu, et al. Design, synthesis and biological evaluation of indole-2-one derivatives as potent BRD4 inhibitors. Eur J Med Chem. 2020 Dec 15;208:112780.?
产品手册
关联产品
  • IRAK4-IN-1

    IRAK4-IN-1 是一种白介素 1 受体相关激酶 4 (IRAK4) 抑制剂,IC50 为 7 nM。

  • 3-methyl-1,2-dihydro...

    3-methyl-1,2-dihydroquinolin-2-one 是第一个已知的 ATAD2 溴结构域微摩尔抑制剂。

  • ODM-207

    BET-IN-4 是一种有效的 BRD4 抑制剂。